Instituto de Pesquisa Clinica Evandro Chagas FIOCRUZ

Rio de Janeiro, Rio de Janeiro 21040-360

0 studies enrolling now · 1 studies all time

What they study most

COVID-19 Pneumonia

Studies at this site

• A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia — Completed